Total Funding
86
57
Total FundingEquity Crowdfunding raised
Growth Score
-5 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
77800
Allergenis is a develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose food allergy.
- Jim Garner: Founder & CEO
About the Company
AllerGenis is a predictive data analytics company specializing in the detection and management of life-threatening immune response disorders including food allergy. Amassing the world’s largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes to gain clinical insights, AllerGenis is
leading the field in developing precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. The company was founded via a collaboration with Hugh Sampson MD, of the Icahn School of Medicine at Mount Sinai. AllerGenis owns and operates a CLIA-certified laboratory in Hatfield, Pennsylvania.
